Christophe Bauer

Title: The Innovations of Christophe Bauer

Introduction

Christophe Bauer is an accomplished inventor based in Strasbourg, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline polymorphs. His work has implications for drug formulation and delivery, enhancing the efficacy and stability of medications.

Latest Patents

Christophe Bauer holds a patent for a "Method for preparing a crystalline polymorph of terazosin." This innovative method involves suspending and treating a crystalline addition product of terazosine hydrochloride and methanol in a polar solvent. The resulting crystalline polymorphous terazosine monohydrochloride is characterized by reduced hygroscopicity and solvent residue retention capacity, making it a valuable advancement in pharmaceutical formulations. He has 1 patent to his name.

Career Highlights

Bauer is currently employed at Cu Chemie Uetikon GmbH, where he continues to explore new avenues in chemical research and development. His expertise in polymorph characterization and drug formulation has positioned him as a key player in his field.

Collaborations

Christophe Bauer collaborates with Jean-Marie Grunenwald, leveraging their combined expertise to drive innovation in pharmaceutical research. Their partnership has led to advancements that benefit the industry and improve patient outcomes.

Conclusion

Christophe Bauer's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his role as a significant inventor. His work continues to influence drug formulation practices, showcasing the importance of innovation in healthcare.